Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma
PHASE2CompletedINTERVENTIONAL
Enrollment
36
Participants
Timeline
Start Date
October 31, 2005
Primary Completion Date
September 30, 2007
Conditions
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris MelanomaRecurrent Intraocular MelanomaRecurrent MelanomaStage IV Melanoma
Interventions
DRUG
carboplatin
Given IV
DRUG
paclitaxel
Given IV
DRUG
bortezomib
Given IV
Trial Locations (1)
55905
Mayo Clinic, Rochester
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00288041 - Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma | Biotech Hunter | Biotech Hunter